You are here: Home News News Recent news and updates from Evox Evox Therapeutics expands its existing exosome patent portfolio 24th Nov 2020 Evox Therapeutics announces launch of strategic collaboration with the University of Oxford 17th Nov 2020 Evox Therapeutics appoints Dr David Lowe as Vice President of Research 13th Oct 2020 Evox Therapeutics expands existing exosome patent portfolio with further grant covering exosomes for RNA therapeutics 15th Jul 2020 Evox Therapeutics announces a multi-target RNA interference and antisense research collaboration and license agreement with Lilly 9th Jun 2020 Evox Therapeutics appoints Martin Andrews as Non-Executive Director 27th May 2020 Pagination Go to page 1Go to page 2Go to page 3
Evox Therapeutics announces launch of strategic collaboration with the University of Oxford 17th Nov 2020
Evox Therapeutics expands existing exosome patent portfolio with further grant covering exosomes for RNA therapeutics 15th Jul 2020
Evox Therapeutics announces a multi-target RNA interference and antisense research collaboration and license agreement with Lilly 9th Jun 2020